-
The Dark Ages of Medicine Are Looming. Can He Save Us?
Sean Brady loves dirt. He’s got an entire closetful of it, in classically brown, cobalt blue and flashy orange. It can come from all over the world, from Mongolian steppes to Little League Baseball diamonds. The exotic stuff is what he really craves, but who knows? Maybe he could find a lifesaving antibiotic in your backyard.
- Categories
- Health Care
-
Swine Flu Adds to Brazil’s Zika Worries
Brazil, which will host the Olympics beginning Aug. 5, was already beset by economic problems, a political crisis and the Zika outbreak. Now it's experiencing its worst swine flu outbreak since 2009. Dr. Melvin Sanicas, a program officer at the Bill & Melinda Gates Foundation, wonders if this will be the crisis that forces a change to the Olympic schedule.
- Categories
- Health Care
-
Combining technologies cracks vaccine chiller issue
Vaccines against killer diseases from polio to hepatitis are fragile and can easily be made useless if they get too hot or too cold. The problem is particularly acute in the developing countries where nearly one in five of the world's population -- 1.3 billion people -- live without access to electricity.
- Categories
- Health Care, Technology
-
India should reject efforts weakening access to generic drugs: MSF
Describing India's pharmaceutical sector a vital life-line for millions of people in developing countries, an international relief organisation on Thursday called on Prime Minister Narendra Modi not to cave in to corporate pressure and support people's access to generic medicines to combat deadly diseases like AIDS.
- Categories
- Health Care
- Region
- South Asia
-
US Army Partners With Sanofi To Develop Zika Vaccine
The vaccine is based on a technology using another virus that has been inactivated, and licensed against Zika-related viruses, such as encephalitis. The technology has also been used to create vaccines for polio, flu and other diseases.
- Categories
- Health Care
-
Limited protection of GSK’s malaria vaccine dwindles in 7 years
The world's first malaria vaccine, developed by GlaxoSmithKline, provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.
- Categories
- Health Care
-
Johns Hopkins Students Design Ebola Protection Suit Improvements
For health workers in the field treating people stricken with Ebola and other diseases, a protective suit is the first defense against infection. The suit and head covering itself, however, can hamper their ability to help by impeding breathing, or heating up so quickly in high temperatures and humidity that they can scarcely work for more than an hour.
- Categories
- Education, Health Care
-
GAVI alliance offers matched funds for GSK malaria vaccine pilot
The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organizations promise to match that commitment.
- Categories
- Health Care
- Region
- Europe & Eurasia
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.